Top Markets
Coin of the day
Spectral Medical Inc. Spectral Medical Inc.

Spectral Medical Inc.

EDT
Classifica tra le azioni #16672
Spectral Medical Inc. focuses on the development and commercialization of... Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Prezzo delle azioni
$0.95411796
Ultima sincronizzazione: 2026-09-01
Capitalizzazione di mercato
$279.96M
Variazione (1 giorno)
-0.76%
Variazione (1 anno)
-16.23%
Paese
CA
Scambia Spectral Medical Inc. (EDT)

Categoria

EPS per Spectral Medical Inc. (EDT)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Spectral Medical Inc., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Spectral Medical Inc. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$18.62 -
US
$5.65 -
US
- -
CN
$-1.36 -
US
$14.24 -
US